Syndecan-4 and fibronectin in osteosarcoma

Pathology

Volumn 44, Issue 4, 2012, Pages 325-330

  Na, Ki Yong ^a   Bacchini, Patrizia ^c   Bertoni, Franco ^d   Kim, Youn Wha ^a   Park, Yong Koo ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Medical Science and Engineering Research Center for Bioreactions to Reactive Oxygen Species   (South Korea)

^c Villa Erbosa Hospital   (Italy)

^d RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Fibronectin; Immunohistochemistry; Osteosarcoma; Syndecan 4

Indexed keywords

EID: 84863681065     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328353447b     Document Type: Article

References (33)

1. Kong C, Hansen MF. Biomarkers in osteosarcoma. Expert Opin Med Diagn 2009; 3: 13-23.
2. Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011; 209: 139-51.
3. Akiyama SK, Olden K, Yamada KM. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 1995; 14: 173-89.
4. Ioachim E, Michael M, Stavropoulos NE, et al. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int 2005; 95: 655-9. (Pubitemid 40311492)
5. Zhang J, Zhi H, Zhou C, et al. Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway. J Pathol 2005; 207: 402-9. (Pubitemid 43025688)
6. Waalkes S, Atschekzei F, Kramer MW, et al. Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer. BMC Cancer 2010; 10: 503.
7. Xian X, Gopal S, Couchman JR. Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 2010; 339: 31-46.
8. Roskams T, De Vos R, David G, et al. Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol 1998; 185: 290-7. (Pubitemid 28320051)
9. Baba F, Swartz K, van Buren R, et al. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. Breast Cancer Res Treat 2006; 98: 91-8. (Pubitemid 44050783)
10. Davies EJ, Blackhall FH, Shanks JH, et al. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin Cancer Res 2004; 10: 5178-86. (Pubitemid 39099793)
11. Crescimanno C, Marzioni D, Paradinas FJ, et al. Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol 1999; 189: 600-8.
12. Williamson D, Selfe J, Gordon T, et al. Role for amplification and expression of glypican-5 in rhabdomyosarcoma. Cancer Res 2007; 67: 57-65. (Pubitemid 46142759)
13. Peterfia B, Hollosi P, Szilak L, et al. Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma. Magy Onkol 2006; 50: 115-20.
14. Reyes CD, Petrie TA, Garcia AJ. Mixed extracellular matrix ligands synergistically modulate integrin adhesion and signaling. J Cell Physiol 2008; 217: 450-8.
15. Harisi R, Dudas J, Timar F, et al. Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture. Cell Biol Int 2005; 29: 959-67. (Pubitemid 41654802)
16. Vial D, Monaghan-Benson E, McKeown-Longo PJ. Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells. Cancer Cell Int 2006; 6: 8.
17. Bodo M, Lilli C, Bellucci C, et al. Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation. Mol Med 2002; 8: 393-404. (Pubitemid 35346219)
18. Song SJ, Cool SM, Nurcombe V. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2. J Cell Biochem 2007; 100: 402-11. (Pubitemid 46146089)
19. Kilian O, Dahse R, Alt V, et al. Expression of EDA+ and EDB+ fibronectin splice variants in bone. Bone 2004; 35: 1334-45. (Pubitemid 40260396)
20. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002; 115: 3861-3. (Pubitemid 35256486)
21. Matsumoto Y, Tanaka K, Harimaya K, et al. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Jpn J Cancer Res 2001; 92: 429-38. (Pubitemid 32427780)
22. Sotobori T, Ueda T, Myoui A, et al. Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res 2006; 312: 3927-38. (Pubitemid 44633892)
23. Gulyas M, Hjerpe A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol 2003; 199: 479-87. (Pubitemid 36411225)
24. Park H, Kim Y, Lim Y, et al. Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem 2002; 277: 29730-6.
25. Fieten H, Spee B, Ijzer J, et al. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Vet Pathol 2009; 46: 869-77.
26. Kloen P, Gebhardt MC, Perez-Atayde A, et al. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression. Cancer 1997; 80: 2230-9. (Pubitemid 28007393)
27. O'Connell MP, Fiori JL, Kershner EK, et al. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells. J Biol Chem 2009; 284: 28704-12.
28. Charni F, Friand V, Haddad O, et al. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochim Biophys Acta 2009; 1790: 1314-26.
29. PosthumaDeBoer J, Witlox MA, Kaspers GJ, et al. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis 2011; 28: 493-503.
30. Thodeti CK, Albrechtsen R, Grauslund M, et al. ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem 2003; 278: 9576-84. (Pubitemid 36800452)
31. Woods A, Couchman JR. Signaling from the matrix to the cytoskeleton: role of cell surface proteoglycans in matrix assembly. Kidney Int Suppl 1996; 54: S64-7. (Pubitemid 26155484)
32. Wang Z, Telci D, Griffin M. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase- fibronectin complex. Exp Cell Res 2011; 317: 367-81.
33. Ren L, Hong SH, Cassavaugh J, et al. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 2009; 28: 792-802.